List of tables
Table 1: Examples of Vaccines with preservatives, Global Vaccines Market, 2020-2028
Table 2: Examples of Adjuvanted Vaccines, Global Vaccines Market, 2020-2028
Table 3: Herd Immunity Threshold for some diseases, Global Vaccines Market, 2020-2028
Table 4: Key Participants in each COVID 19 Vaccine, Global Vaccines Market, 2020-2028
Table 5: Buyer’s Bargaining Power, Global Personal Protection Equipment Market, 2020-2028
Table 6: Supplier’s Bargaining Power, Global Vaccine Market, 2020-2028
Table 7: Threat of New Entrants, Global Vaccine Market, 2020-2028
Table 8: Threat of Substitutes, Global Vaccine Market, 2020-2028
Table 9: Competitive Rivalry, Global Personal Protection Equipment Market, 2020-2028
Table 10: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 11: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 12: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 13: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 14: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 15: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 16: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 17: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 18: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 19: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 20: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-202
Table 21: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 22: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 23: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 24: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 25: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 26: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 27: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 28: Vaccination Coverage (in Percentage), Global Vaccines Market,2020-2028
Table 29: Total Cases and Deaths due to major epidemics (In Numbers, As of 30 April’2020 data), Global Vaccines Market,2020-2028
Table 30: Vaccines Market Forecast (Region wise in USD Billion), Global, 2018-2028
Table 31: North America Market Forecast (Disease Indication wise in USD Billion), 2018-2028
Table 32: Europe Market Forecast (Disease Indication wise in USD Billion), 2018-2028
Table 33: APAC Market Forecast (Disease Indication wise in USD Billion),  2018-2028
Table 34: Middle East Market Forecast (Disease Indication wise in USD Billion), 2018-2028
Table 35: LATAM Market Forecast (Disease Indication wise in USD Billion), 2018-2028
Table 36: Rest of the World Market Forecast (Disease Indication wise in USD Billion), 2018-2028
Table 37: North America Market Forecast (Patient Type wise in USD Billion), 2018-2028
Table 38: Europe Market Forecast (Patient Type wise in USD Billion), 2018-2028
Table 39: APAC Market Forecast (Patient Type wise in USD Billion), 2018-2028
Table 40: Middle East Market Forecast (Form wise in USD Billion), 2018-2028
Table 41: LATAM Market Forecast (Patient Type wise in USD Billion), 2018-2028
Table 42: Rest of the World Market Forecast (Patient Type wise in USD Billion), 2018-2028
Table 43: Vaccines Market Forecast (Technology wise in USD Billion), Global, 2018-2028
Table 44: Conjugate Vaccines Market Forecast (Type wise in USD Billion), Global, 2018-2028
Table 45: Inactivated and subunit Vaccines Market Forecast (Type wise in USD Billion), Global, 2018-2028
Table 46: Live attenuated Vaccines Market Forecast (Type wise in USD Billion), Global, 2018-2028
Table 47: Recombinant Vaccine Market Forecast (Type wise in USD Billion), Global, 2018-2028
Table 48: Toxoid Vaccines Market Forecast (Type wise in USD Billion), Global, 2018-2028
Table 49: Conjugate Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 50: Inactivated and subunit Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 51: Live attenuated Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 52: Recombinant Vaccine Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 53: Toxoid Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 54: Vaccines Market Forecast (End-Use Industry wise in USD Billion), Global, 2018-2028
Table 55: Pediatic Patients Vaccines Market Forecast (Technology wise in USD Billion), Global, 2018-2028
Table 56: Adult Patients Market Forecast (Technology wise in USD Billion), Global, 2018-2028
Table 57: Pediatic Patients Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 58: Adult Patients Market Forecast (Mode of Administration wise in USD Billion), Global, 2018-2028
Table 59: Vaccines Market Forecast (USD Billion), Corona Impact CS-1, 2020-2028
Table 60: Vaccines Market Forecast (USD Billion), Corona Impact CS-2, 2020-2028
Table 61: Vaccines Market Forecast (USD Billion), Corona Impact CS-3, 2020-2028
Table 62: Vaccines market (In USD Billion), Scenario Analysis, 2020-2028
Table 63: Vaccines market (In USD Billion), Scenario 1 Analysis, 2020-2028
Table 64: Global Vaccines market (In USD Billion), Scenario 1 Factors, 2020-2028
Table 65: Vaccines market (In USD Billion), Scenario 1 Analysis, 2020-2028
Table 66: Vaccines market (In USD Billion), Scenario 2 Analysis, 2020-2028
Table 67: Vaccines market (In USD Billion), Scenario 2 Factors, 2020-2028
Table 68: Vaccines market (In USD Billion), Scenario 2 Industry wise Analysis, 2020-2028
Table 69: Pfizer Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 70: Sanofi Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 71: GlaxoSmithKline Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 72: Johnson & Johnson Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 73: Merck & Co. Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 74: Novavax Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 75: CSL Limited Financial Information 2015 – 2019 (USD Billions), Global Vaccines market
Table 76: AstraZeneca Financial Information 2017 – 2019 (USD Billions), Global Vaccines market
Table 77: Inovio Pharmaceuticals Financial Information 2016 – 2019 (USD Billions), Global Vaccines market
Table 78: Emergent BioSolutions Financial Information 2015 – 2019 (USD Billions), Global Vaccines market

 
List of figures
Figure 1: Comparison of the Immune Response to a disease-causing Organism and to a Vaccine, Global Vaccines Market, 2020-2028
Figure 2: Progress of Polio Elimination 1988 and 2014, Global Vaccines Market, 2020-2028
Figure 3: Antibody destruction by antigen, Global Vaccines Market, 2020-2028
Figure 4: Live Attenuated Vaccine, Global Vaccines Market, 2020-2028
Figure 5: Inactivated Vaccine, Global Vaccines Market, 2020-2028
Figure 6: Global Vaccine Coverage in 2018, Global Vaccines Market, 2020-2028
Figure 7: Phases of Vaccine Development, Global Vaccines Market, 2020-2028
Figure 8: Exploring the drug development process, Global Vaccines Market, 2020-2028
Figure 9: Clinical Trials, Global Vaccines Market, 2020-2028
Figure 10: Professionals involved in Vaccine Development, Global Vaccines Market, 2020-2028
Figure 11: Immunization policy in US, Global Vaccines Market, 2020-2028
Figure 12: Immunization in Europe, Global Vaccines Market, 2020-2028
Figure 13: Immunization in APAC, Global Vaccines Market, 2020-2028
Figure 14: COVID-19 Virus, Global Vaccine Market, 2020-2028
Figure 15: Covid 19 Vaccine, Global Vaccine Market, 2020-2028
Figure 16: COVID 19- Projected timeline for treatment and prevention, Global Vaccine Market, 2020-2028
Figure 17: COVID 19- Possible treatment and prevention, Global Vaccine Market, 2020-2028
Figure 18: Reverse Vaccinology | Bexsero(meningococcal group B vaccine), Global Vaccines Market, 2020-2028
Figure 19: Structural Vaccinology, Global Vaccine Market, 2020-2028
Figure 20: Immunoprophylaxis by gene versus Traditional Passive Immunization, Global Vaccine Market, 2020-2028
Figure 21: Activation and use of prefilled bubble-like auto-disable injection, Global Vaccine Market, 2020-2028
Figure 22: Needle free vaccine injection, Global Vaccine Market, 2020-2028
Figure 23: Cross-section of Nanopatch Technology, Global Vaccine Market, 2020-2028
Figure 24: Heartwater disease in animals, Global Vaccine Market, 2020-2028
Figure 25: Mucosal Vaccination, Global Vaccine Market, 2020-2028
Figure 26: Synthetic Antigen Vaccine, Global Vaccine Market, 2020-2028
Figure 27: DNA Vaccine, Global Vaccine Market, 2020-2028
Figure 28: Key Drivers, Global Vaccine Market, 2020-2028
Figure 29: Global number of Child deaths due to infectious disease, Global Vaccine Market, 2020-2028
Figure 30: Global Alliance Partner for Vaccination and Immunization(GAVI) , Global Vaccine Market, 2020-2028
Figure 31: Vaccine Ecosystem Interdependancies Chart, Global Vaccine Market, 2020-2028
Figure 32: Total confirmed COVID-19 deaths per million people, Global Vaccine Market, 2020-2028
Figure 33: Key Restraints, Global Vaccines Market, 2020-2028
Figure 34: Vaccine development timeline, Global Vaccine Market, 2020-2028
Figure 35: Key Challenges, Global Personal Protection Equipment Market, 2020-2028
Figure 36: Percentage of respondents for major challenges to vaccine delivery systems, Global Vaccines Market, 2020-2028
Figure 37: Challenges and human responses in Vaccine Development, Global Vaccines Market, 2020-2028
Figure 38: Porter’s Five Forces, Global Vaccines Market, 2020-2028
Figure 39:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 40:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 41:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 42:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 43:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 44:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 45:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 46:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 47:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 48:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 49:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 50:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 51:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 52:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 53:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 54:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 55:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 56:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 57:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 58:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 59:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 60:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 61:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 62:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 63:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 64:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 65:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 66:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 67:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 68:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 69:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 70:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 71:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 72:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 73:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 74:  Epidemic Response Index, Global Vaccines Market,2020-2028
Figure 75:  Government Expenditure on Healthcare (In Percentage), Global Vaccines Market,2020-2028
Figure 76:  Incidence of vaccine preventable diseases, Global Vaccines Market,2020-2028
Figure 77:  Total Cases and Deaths due to major epidemics (In Numbers), Global Vaccines Market,2020-2028
Figure 78: Vaccines Market Forecast (Region wise in USD Billion), Global, 2018- 2028
Figure 79: Vaccines Market Forecast (Region wise, In Percent), Global, 2020-2028
Figure 80: North America Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 81: North America, Vaccines Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 82: Europe Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 83: Europe, Vaccine Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 84: APAC Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 85: APAC, Vaccines Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 86: Middle East Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 87: Middle East, Vaccines Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 88: LATAM Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 89: LATAM, Vaccines Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 90: Rest of the World Market Forecast (Disease Indication wise in USD Billion), 2020
Figure 91: Rest of the World, Vaccines  Market Forecast (In Percent), By Disease Indication, 2020-2028
Figure 92: North America Market Forecast (Patient Type wise in USD Billion), 2020
Figure 93: North America, Vaccines  Market Forecast (In Percent), By Patient Type, 2020-2028
Figure 94: Europe Market Forecast (Patient Type wise in USD Billion), 2020
Figure 95: Europe, Vaccines Market Forecast (In Percent), By Form, 2020-2028
Figure 96: APAC Market Forecast (Patient Type wise in USD Billion), 2020
Figure 97: APAC, Vaccines Market Forecast (In Percent), By Patient Type, 2020-2028
Figure 98: Middle East Market Forecast (Patient Type wise in USD Billion), 2020
Figure 99: Middle East, Vaccines Market Forecast (In Percent), By Patient Type, 2020-2028
Figure 100: LATAM Market Forecast (Patient Type wise in USD Billion), 2020
Figure 101: LATAM, Vaccines Market Forecast (In Percent), By Patient Type, 2020-2028
Figure 102: Rest of the World Market Forecast (Patient Type wise in USD Billion), 2020
Figure 103: Rest of the World, Vaccines Market Forecast (In Percent), By Patient Type, 2020-2028
Figure 104: Vaccines Market Forecast (Technology wise in USD Billion), Global, 2018-2028
Figure 105: Vaccines Market Forecast (Technology wise In Percent), Global, 2020-2028
Figure 106: Conjugate Vaccines Market Forecast (Type wise in USD Billion), Global, 2020
Figure 107: Conjugate Vaccines, Vaccines Market Forecast (In Percent), By Type, 2020-2028
Figure 108: Inactivated and subunit Vaccines Market Forecast (Type wise in USD Billion), Global, 2020
Figure 109: Inactivated and subunit Vaccines, Vaccines Market Forecast (In Percent), By Type, 2020-2028
Figure 110: Live attenuated Vaccines, Market Forecast (Type wise in USD Billion), Global, 2020
Figure 111: Live attenuated Vaccines, Vaccines Market Forecast (In Percent), By Type, 2020-2028
Figure 112: Recombinant Vaccine Market Forecast (Type wise in USD Billion), Global, 2020
Figure 113: Recombinant Vaccine, Vaccines Market Forecast (In Percent), By Type, 2020-2028
Figure 114: Toxoid Vaccines Market Forecast (Type wise in USD Billion), Global, 2020
Figure 115: Toxoid Vaccines, Vaccines Market Forecast (In Percent), By Type, 2020-2028
Figure 116: Conjugate Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 117: Conjugate Vaccines, Vaccines Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 118: Inactivated and subunit Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 119: Inactivated and subunit Vaccines, Vaccines Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 120: Live attenuated, Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 121: Live attenuated, Vaccines Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 122: Recombinant Vaccine Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 123: Recombinant Vaccine, Vaccines Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 124: Toxoid Vaccines Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 125: Toxoid Vaccines, Vaccines Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 126: Vaccines Market Forecast (Source wise in USD Billion), Global, 2018-2020
Figure 127: Vaccines Market Forecast (End-Use Industry wise In Percent), Global, 2020-2028
Figure 128: Pediatic Patients Vaccines Market Forecast (Technology wise in USD Billion), Global, 2020
Figure 129: Pediatic Patients, Vaccines Market Forecast (In Percent), By Technology, 2020-2028
Figure 130: Adult Patients Market Forecast (Technology wise in USD Billion), Global, 2020
Figure 131: Adult Patients, Vaccines Market Forecast (In Percent), By Technology, 2020-2028
Figure 132: Pediatic Patients Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 133: Pediatic Patients Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 134: Adult Patients Market Forecast (Mode of Administration wise in USD Billion), Global, 2020
Figure 135: Adult Patients Market Forecast (In Percent), By Mode of Administration, 2020-2028
Figure 136: Global Vaccines Market (USD Billions), Corona Impact, 2020-2028
Figure 137: Global Vaccines Market (USD Billions), Corona Impact, 2020-2028
Figure 138: Global Vaccines Market (USD Billions), Revenue Impact due to Corona on Vaccines Market, 2020-2028
Figure 139: Global Vaccines Market (USD Billions), Corona Impact CS-1, 2020-2028
Figure 140: Global Vaccines Market (USD Billions), Corona Impact CS-2, 2020-2028
Figure 141: Global Vaccines Market (USD Billions), Corona Impact CS-3, 2020-2028
Figure 142: Vaccines market (In USD Billion), Scenario Analysis, 2020-2028
Figure 143: Vaccines market (In USD Billion), Scenario 1 Analysis, 2020-2028
Figure 144: Vaccines market (In USD Billion), Scenario 1 Type wise Analysis, 2020-2028
Figure 145: Vaccines market (In USD Billion), Scenario 2 Analysis, 2020-2028
Figure 146: Vaccines market (In USD Billion), Scenario 2 Industry wise Analysis, 2020-2028
Figure 147: Global Vaccines Market Forecast (In USD Billion), 2020-2028
Figure 148: Global Vaccines Market CAGR (In Percentage), 2020-2028
Figure 149: Global Vaccines Market Forecast (In USD Billion), 2020-2028
Figure 150: Global Vaccines Market CAGR (In Percentage), 2020-2028
Figure 151: Global Vaccines Market Forecast (In USD Billion), 2020-2028
Figure 152: Global Vaccines Market CAGR (In Percentage), 2020-2028
Figure 153: Pfizer Company Revenue of 2019,Global Vaccines Market, 2020-2028
Figure 154: Pfizer Company Revenue 2015 - 2019 (USD Billions)
Figure 155: Pfizer Company Profit 2015 - 2019 (USD Billions)
Figure 156: Sanofi Revenue of 2018,Global Personal Protective Market Market, 2020-2028
Figure 157: Sanofi Revenue 2015 - 2019 (USD Billions)
Figure 158: Sanofi Profit 2015 - 2019 (USD Billions)
Figure 159: GlaxoSmithKline Company Revenue of 2019,Global Vaccines Market, 2020-2028
Figure 160: GlaxoSmithKline Company Revenue 2015 - 2019 (USD Billions)
Figure 161: GlaxoSmithKline Company Profit 2015 - 2019 (USD Billions)
Figure 162: Johnson & Johnson Company Revenue of 2018,Global Vaccines Market, 2020-2028
Figure 163: Johnson & Johnson Company Revenue 2015 - 2019 (USD Billions)
Figure 164: Johnson & Johnson Company Profit 2015 - 2019 (USD Billions)
Figure 165: Merck Company Revenue of 2018,Global Vaccines Market, 2020-2028
Figure 166: Merck & Co. Company Revenue 2015 - 2019 (USD Millions)
Figure 167: Merck & Co. Company Profit 2015 - 2019 (USD Millions)
Figure 168: Novavax Company Revenue 2015 - 2019 (USD Billions)
Figure 169: CSL Limited Company Revenue 2015 - 2019 (USD Billions)
Figure 170: CSL Limited Company Profit 2015 - 2019 (USD Billions)
Figure 171: AstraZenca Company Revenue of 2018,Global Vaccines Market, 2020-2028
Figure 172: AstraZeneca Company Revenue 2017 – 2019 (USD Billions)
Figure 173: AstraZeneca Company Profit 2017 – 2019 (USD Billions)
Figure 174: Inovio Pharmaceuticals Company Revenue 2015 - 2019 (USD Billions)
Figure 175: Inovio Pharmaceuticals Company Profit 2015 - 2019 (USD Billions)
Figure 176: Emergent BioSolutions Company Revenue 2015 - 2019 (USD Billions)
Figure 177: Emergent BioSolutions Company Profit 2015 - 2019 (USD Billions)